Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
24 weeks: Long-term evaluation
These included CT-996, a once-daily oral small-molecule oral GLP-1 receptor agonist, in Phase I, for treating obesity in patients with and without Type 2 diabetes, as well as two injectable clinical drug candidates: CT-388, a once-weekly subcutaneous injectable in Phase II, for treating obesity in patients with and without Type 2 diabetes, and CT-868, a once-daily subcutaneous injectable, in Phase II, for treating Type 1 diabetes patients with overweight or obesity
Our Specialties Artists Injuries Learn More Elbow Pain Learn More Joint Pain Learn More Back Pain Learn More Personalized Physical Therapy in Pittsburgh From Our Team Your body changes daily, and your treatment should evolve with it
Cosmetic-grade copper tripeptide-1 is a formulated topical product subject to cosmetic regulation, with no comparable analytical disclosure
Supplied as a stable freeze-dried powder, it is strictly intended for laboratory and in-vitro research applications only
US$ 24.89
US$ 25.04
US$ 22.10
US$ 20.88
US$ 25.96
US$ 29.50
US$ 24.96
US$ 28.34
US$ 27.80
US$ 28.45
US$ 20.16
